Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1453 studies found for:    Open Studies | "Lymphatic Diseases"
Show Display Options
Rank Status Study
21 Recruiting ACP-196 in Combination With ACP-319, for Treatment of Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Interventions: Drug: ACP-196 and ACP-319;   Drug: ACP-319 and ACP-196
22 Unknown  PRO Development for ANCA Associated Vasculitis
Conditions: Wegener Granulomatosis;   Microscopic Polyangiitis;   Churg-Strauss Syndrome
23 Recruiting Exergaming Intervention in ALL Patients
Condition: Acute Lymphoblastic Leukemia
Intervention: Behavioral: Exergaming Program
24 Recruiting Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma
Conditions: Adult Lymphocyte Depletion Hodgkin Lymphoma;   Adult Lymphocyte Predominant Hodgkin Lymphoma;   Adult Mixed Cellularity Hodgkin Lymphoma;   Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma;   Adult Nodular Sclerosis Hodgkin Lymphoma;   Recurrent Adult Hodgkin Lymphoma
Interventions: Drug: gemcitabine hydrochloride;   Drug: bendamustine hydrochloride
25 Recruiting Phase II Study With Ga101-DHAP as Induction Therapy in Relapsed/Refractory DLBCL Patients Before High-Dose Chemotherapy BEAM With ASCT (GIOTTO)
Condition: Diffuse, Large B-Cell, Lymphoma
Intervention: Drug: GA101_DHAP
26 Unknown  Clinical Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT)
Conditions: Leukemia;   Chronic Myeloid Leukemia;   Myelodysplastic Syndrome;   Diffuse Large Cell Lymphoma;   Hodgkin Lymphoma;   Chronic Lymphocytic Leukemia;   Multiple Myeloma
Intervention: Drug: Treosulfan IV
27 Recruiting Osteonecroses in Pediatric Patients With ALL
Conditions: Osteonecrosis;   Acute Lymphoblastic Leukaemia;   Lymphoblastic Lymphoma
28 Recruiting An Open-label, Phase 1b Study of ACP 196 in Subjects With Waldenström Macroglobulinemia
Condition: Waldenström Macroglobulinemia (WM)
Intervention: Drug: ACP-196
29 Recruiting Bruton's Tyrosine Kinase (BTK) Inhibition in B-cell Lymphomas
Condition: B-cell Lymphoma
Intervention: Drug: Ibrutinib and immunochemotherapies
30 Recruiting Carbohydrate Metabolism Disorder Frequency in Hypertriglyceridemia Induced by Bexarotene of Cutaneous T Cell Lymphoma
Conditions: Hypertriglyceridemia;   Cutaneous T Cell Lymphoma
Intervention: Other: oral glucose tolerance test (OGTT)
31 Recruiting Study of IPI-145 in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular Lymphoma
Condition: Follicular Lymphoma
Interventions: Drug: IPI-145 (duvelisib);   Drug: Placebo;   Drug: Rituximab
32 Recruiting International Rare Histiocytic Disorders Registry (IRHDR)
Conditions: Rare Histiocytic Disorders (RHDs);   Juvenile Xanthogranuloma (JXG);   Reticulohistiocytoma (Epithelioid Histiocytoma);   Xanthoma Disseminatum (XD);   Multicentric Reticulohistiocytosis (MRH);   Systemic Juvenile Xanthogranuloma;   Erdheim-Chester Disease (ECD);   Multi-system Rosai-Dorfman Disease (RDD)
Intervention: Other: Registry study
33 Recruiting Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy
Conditions: Breast Cancer;   Lymphoma
34 Recruiting A Study of Dasatinib in Chronic Lymphocytic Leukemia in Patients Who Exhibit in Vitro Dasatinib Sensitivity
Condition: Chronic Lymphocytic Leukemia (CLL)
Intervention: Drug: Dasatinib
35 Unknown  Phase 1 Study of OPB-31121 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma
Conditions: Non-Hodgkin's Lymphoma(NHL);   Multiple Myeloma(MM)
Intervention: Drug: OPB-31121
36 Recruiting MSC and HSC Coinfusion in Mismatched Minitransplants
Conditions: Leukemia, Myeloid, Acute;   Leukemia, Lymphoblastic, Acute;   Leukemia, Myelocytic, Chronic;   Myeloproliferative Disorders;   Myelodysplastic Syndromes;   Multiple Myeloma;   Leukemia, Lymphocytic, Chronic;   Hodgkin's Disease;   Lymphoma, Non-Hodgkin
Interventions: Biological: Mesenchymal stem cells;   Other: Isotonic solution
37 Recruiting Acute Lymphoblastic Leukemia Registry at Asan Medical Center
Conditions: Leukemia, Acute Lymphoblastic;   Precursor B-Cell Lymphoblastic Leukemia;   Leukemia, Biphenotypic, Acute;   Leukemia, Lymphoblastic, Acute, Philadelphia-Positive;   Lymphoblastic Lymphoma
Intervention: Other: Diagnosed as ALL
38 Recruiting Treatment for Executive Dysfunction in Adult Survivors of Childhood Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Device: transcranial Direct Current Stimulation (tDCS);   Device: Sham;   Other: Cognitive Assessment;   Other: Brain Games Stimulation
39 Unknown  LMBA02 Protocol for Patients With a Burkitt Lymphoma
Condition: Burkitt Lymphoma
Intervention: Drug: rituximab
40 Not yet recruiting Mild-dose IMRT for Early-staged Extranodal Nasal-type NK/T-cell Lymphoma With CR Tumor After GELOX Chemotherapy
Conditions: Lymphoma,;   Non-Hodgkin Lymphoma,;   Extranodal NK/T-cell Lymphoma,Nasal-type,
Intervention: Radiation: Mild-dose IMRT

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years